BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.97
+0.13 (1.47%)
At close: May 29, 2026, 4:00 PM EDT
8.94
-0.03 (-0.33%)
After-hours: May 29, 2026, 4:10 PM EDT
BridgeBio Oncology Therapeutics Employees
BridgeBio Oncology Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 30 or 48.39% compared to the previous year.
Employees
92
Change
30
Growth
48.39%
Revenue / Employee
n/a
Profits / Employee
-$1,674,946
Market Cap
718.56M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Sep 30, 2025 | 81 | 19 | 30.65% |
| Mar 31, 2025 | 62 | - | - |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CorMedix | 191 |
| Cabaletta Bio | 156 |
| Solid Biosciences | 121 |
| Aclaris Therapeutics | 73 |
| Alto Neuroscience | 68 |
| Zevra Therapeutics | 61 |
| Crescent Biopharma | 55 |
| Design Therapeutics | 54 |
BBOT News
- 17 days ago - BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 17 days ago - BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - BridgeBio Oncology Therapeutics Earnings release: Q1 2026 - Filings
- 17 days ago - BridgeBio Oncology Therapeutics Quarterly report: Q1 2026 - Filings
- 18 days ago - BridgeBio Oncology initiated with a Buy at Canaccord - TheFly
- 18 days ago - BridgeBio Oncology initiated with a Buy at Canaccord - TheFly
- 4 weeks ago - BridgeBio Oncology Therapeutics Proxy statement: Proxy filing - Filings
- 4 weeks ago - BridgeBio Oncology Therapeutics Proxy statement: Proxy filing - Filings